Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kerr

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
The New Zealand Medical Journal|August 16, 2019
A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New ZealandAndrew Kerr, Sue Wells, Allan Moffitt, et al.
IEEE Reviews in Biomedical Engineering|July 1, 2022
A Mapping Review of Real-Time Movement Sonification Systems for Movement RehabilitationThomas H Nown, Priti Upadhyay, Andrew Kerr, et al.
Internal Medicine Journal|May 25, 2020
Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS-QI-43 studyTom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
Nephrology (Carlton, Vic.)|February 28, 2020
Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: A nationwide data linkage study (ANZACS-QI 44)Helen L Pilmore, Fei Xiong, Yeunhyang Choi, et al.
Journal of Medical Physics|January 26, 2010
Practical and clinical considerations in Cobalt-60 tomotherapyChandra P Joshi, Sandeep Dhanesar, Johnson Darko, et al.
JAMA|June 28, 2018
Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet TherapyVanessa Selak, Andrew Kerr, Katrina Poppe, et al.
The New Zealand Medical Journal|June 30, 2020
Performance of CVD risk equations for older patients assessed in general practice: a cohort studySue Wells, Romana Pylypchuk, Suneela Mehta, et al.
Frontiers in Public Health|June 7, 2014
The HEART Mobile Phone Trial: The Partial Mediating Effects of Self-Efficacy on Physical Activity among Cardiac PatientsRalph Maddison, Leila Pfaeffli, Ralph Stewart, et al.
Health Policy (Amsterdam, Netherlands)|October 19, 2017
Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute riskChris Schilling, Josh Knight, Duncan Mortimer, et al.
The New Zealand Medical Journal|February 7, 2013
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practiceDoone Winnard, Craig Wright, Gary Jackson, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
The New Zealand Medical Journal|August 16, 2019
A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New ZealandAndrew Kerr, Sue Wells, Allan Moffitt, et al.
IEEE Reviews in Biomedical Engineering|July 1, 2022
A Mapping Review of Real-Time Movement Sonification Systems for Movement RehabilitationThomas H Nown, Priti Upadhyay, Andrew Kerr, et al.
Internal Medicine Journal|May 25, 2020
Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS-QI-43 studyTom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
Nephrology (Carlton, Vic.)|February 28, 2020
Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: A nationwide data linkage study (ANZACS-QI 44)Helen L Pilmore, Fei Xiong, Yeunhyang Choi, et al.
Journal of Medical Physics|January 26, 2010
Practical and clinical considerations in Cobalt-60 tomotherapyChandra P Joshi, Sandeep Dhanesar, Johnson Darko, et al.
JAMA|June 28, 2018
Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet TherapyVanessa Selak, Andrew Kerr, Katrina Poppe, et al.
The New Zealand Medical Journal|June 30, 2020
Performance of CVD risk equations for older patients assessed in general practice: a cohort studySue Wells, Romana Pylypchuk, Suneela Mehta, et al.
Frontiers in Public Health|June 7, 2014
The HEART Mobile Phone Trial: The Partial Mediating Effects of Self-Efficacy on Physical Activity among Cardiac PatientsRalph Maddison, Leila Pfaeffli, Ralph Stewart, et al.
Health Policy (Amsterdam, Netherlands)|October 19, 2017
Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute riskChris Schilling, Josh Knight, Duncan Mortimer, et al.
The New Zealand Medical Journal|February 7, 2013
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practiceDoone Winnard, Craig Wright, Gary Jackson, et al.
Pageof 14